In a melanoma mouse model, the use of an anti-KLRG1 antibody alone moderately depleted intratumoral Tregs but not peripheral Tregs, which prevented the autoimmune side effects caused by systemic depletion of Tregs [25, 129]. The gene discussed is KLRG1; the disease is melanoma.